Search | Sort | Filter
Kelly Erhart, Co-Founder of Project Vesta, talks about what they see as one of the...
In the wake of Silicon Valley Bank’s failure earlier this month, many technology...
Startups that develop, use or commercialize AI systems or general-purpose AI models used...
How to manage a joint IPO and sale exit.
Biotech firms must assess AI's impact on research protection. Recent U.S. PTO guidance...
M&A ready? Hear from Orrick’s Zac Padgett on the right mindset for AI due diligence.
Companies face an increasing and unprecedented risk of inadvertently possessing illegal...
Konrad Alt shares his unique perspective on the evolution of financial services...
Learn how to describe your business for SEC disclosure.
The new SREN law adapts French legislation to new EU regulations, including the Digital...
We share what companies need to know about data handling practices and transactions that...
You are looking to bring employees, consultants, and/or advisors into your startup. What...
Securing global software IP rights is vital. Beware template agreements; IP varies by...
Orrick's Life Sciences team explores how the healthcare industry is bracing for...
You’ve received capital from an investor to fuel your company’s growth. What kind of...
Recommendations for companies to avoid potential actions from the SEC and other agencies,...
Orrick advised biotech company OKYO Pharma on its initial public offering on...
In this Life Sciences & Healthtech edition of The Download, we take on key trends with...
Orrick is advising VEF on its listing on Nasdaq Stockholm’s Main Market.
Aravind Swaminathan shares his insights on CISOs as strategic partners, crisis...